Clik here to view.
CMA fines pharmaceutical companies £45 million
The UK Competition and Markets Authority (CMA) has fined a number of pharmaceutical companies for anti-competitive conduct and agreements in relation to the supply of paroxetine. The CMA’s decision...
View ArticleClik here to view.
Maternal immunisation
Childhood vaccination was one of the most significant medical success stories of the 20th century with vaccines making diseases such as measles, whooping cough and rubella much more unlikely. New and...
View ArticleClik here to view.
GSK presents data on of Nucala in asthma patients stratified by eosinophil...
Data from a post-hoc study show that severe asthma patients with a baseline blood eosinophil count of 150 cells/μL or above who received GSK’s Nucala (100mg fixed dose subcutaneous injection of...
View ArticleClik here to view.
GSK’s Advair Diskus achieves primary endpoint in LABA safety study
GSK has announced results from the paediatric ‘LABA’ (long acting beta2-agonist) safety study. The VESTRI study compared Advair Diskus (FSC), a combination of the LABA, salmeterol, and the inhaled...
View ArticleClik here to view.
Sir Andrew Witty to retire as CEO of GSK
GSK has announced that Sir Andrew Witty, CEO, has indicated to the Board his intention to retire from the company in early 2017. Sir Andrew Witty CREDIT: GSK GSK’s Board has agreed that he will retire...
View ArticleClik here to view.
Current trends in freeze-drying
Controlled nucleation is one of the most topical trends in the industry, as the freezing step is of paramount importance for stability of products. The temperature range between 0°C and the real...
View Article